{"name":"Italo Biaggioni","slug":"italo-biaggioni","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Moxonidine 0.2 MG","genericName":"Moxonidine 0.2 MG","slug":"moxonidine-0-2-mg","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Moxonidine 0.2 MG","genericName":"Moxonidine 0.2 MG","slug":"moxonidine-0-2-mg","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMic0FVX3lxTE5xdFVQdFNlV3lPSHQxc1FTWXpQb2pvNTFTd25IRHFQN3U5NGpQeW5XdnRJek00Vzc4WUdDRnBUdWItWHQ4YjAxb1gzM1RpdDl3TDZtRmlMd2k2YXJlYXlVQ3RpSkVrd1h4MHBNV1J4UklKemc?oc=5","date":"2024-08-07","type":"pipeline","source":"American Heart Association Journals","summary":"Hyperadrenergic Postural Tachycardia Syndrome: Clinical Biomarkers and Response to Guanfacine - American Heart Association Journals","headline":"Hyperadrenergic Postural Tachycardia Syndrome: Clinical Biomarkers and Response to Guanfacine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxNWFo5RWJUTVUtUGt3MVZGR1BvczQxc1AyLU5QSTlwS0gySjJCWlQzUWJ0ODZjQ2ZTallWbE1PZ25oVExybktHWUJRQXFYeVdWZkhpTVVLWmxnVmdSRGxvcTJIT1NBM3BoV0FwN1RIMHZNNHIzNVA3ak4yZ1VSWVhGYkhsT0pPbWs3M0pzVTZMT1Y0UEJZSkhOb0lQOXNPdl9mb2dUdmkyRnN6SDJpbVQ3dUNnQ3NvaTlCQVZMdVM4SGJzZzJqWGtzajROaExKMDRUcHBhYnpsNkxfUDQ?oc=5","date":"2022-11-07","type":"pipeline","source":"American Heart Association Journals","summary":"Management of Patients With Hypertension and Orthostatic Hypotension. Parallel Progress - American Heart Association Journals","headline":"Management of Patients With Hypertension and Orthostatic Hypotension. Parallel Progress","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgJBVV95cUxPR0ZyR2h3QVdZMDlZNExBd0Y1Tm9TUG1mYVBZUGhkc1k0bUFFa3R0SnNwZl92dldpSTZNZW5CeDdGbmFaZzdnTldDREtMRXJGWlc4Uk01Nk9aQlBUcmZwdUp2REFMak1wdmZlMDlzUkRHVXBvWXVqUHN1UnpFTHBzTVJDc2ZTeVRsUS01WVFoZnVvdVhxMjlHQnNzN2JwMlZ5TGpkX0xsaTlMbmpOMndhc29vQUJaSkFkQXgyYXl3UE03ZjJqc3hBanVoZFJWY1dlY05OQkhTUVhkQWVBNGZFZlRkTkxNZmYtZ3ctRzdCRnFNUzh0QlZOdTdpZFZ5NGhsZEFBX3Vn?oc=5","date":"2021-11-03","type":"pipeline","source":"newsroom.heart.org","summary":"Italo Biaggioni, M.D., Ph.D., FAHA, of Vanderbilt University to be named the American Heart Association’s 2021 Distinguished Scientist in Hypertension - newsroom.heart.org","headline":"Italo Biaggioni, M.D., Ph.D., FAHA, of Vanderbilt University to be named the American Heart Association’s 2021 Distingui","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}